Both of these hormones affect your appetite by slowing down the emptying of the stomach after a meal
These medications work by mimicking the GLP-1 hormone at pharmaceutical concentrations, directly affecting appetite regulation, gastric emptying, and insulin response
Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial. New England Journal of Medicine
FDA-approved branded medications containing semaglutide or tirzepatide - Ozempic, Wegovy, Mounjaro, and Zepbound - are finished drug products approved by FDA based on applicable review standards for safety, effectiveness, and quality
Lancet 1980, 1: 1310-1311
The variation isn't clinical nuance